Reference library
Compounds.
30 entries. Mechanism, routes, evidence, risk, and what is worth tracking. Sourced and dated. No claims, no testimonials.
Metabolic
GLP-1, GIP, glucagon, amylin, appetite, weight, GI tolerance.
Recovery
Tissue repair, skin, hair, immune modulation, local response.
Cognition / sleep
Intranasal stacks, sleep, mood, focus, adjustment effects.
Mitochondrial / adjacent
Energy, HRV, training, clinic-wellness overlap.
- MOTS-c Energy, training, HRV, fatigue →
- NAD+ Form, route, cost, energy/sleep response →
- NMN Brand/batch, daily dose, methylation support, energy/sleep trend →
- Methylene blue Medication interactions, brand/grade, dose, cognitive ratings →
- SS-31 (Elamipretide) Indication target, energy/PEM, batch/source, cycle position →
Growth hormone axis
GHRP and GHRH compounds, sleep architecture, recovery.
- Ipamorelin Sleep quality, stack composition, water-retention notes →
- CJC-1295 Form (DAC vs no-DAC), stack composition, IGF-1 trend →
- Sermorelin Access route (compounded vs research-chem), stack, sleep quality →
- Tesamorelin Protocol (1mg vs 2mg), waist, IGF-1, fluid retention →
- MK-677 (Ibutamoren) Daily dose, glucose, BP, fluid retention, hunger →
Sexual function
Centrally-acting compounds for desire, arousal, and erectile response.
Antimicrobial / chronic infection
Antimicrobial peptides for chronic-infection support and biofilm disruption.
Pigmentation
UV-independent tanning via melanocortin pathways — with documented safety concerns.
Lipolytic / fat loss
Compounds targeting adipose tissue lipolysis without GH-axis effects.